@article{8f83ea4e62ea43a6a4c82d6ac52bd212,
title = "Intravascular ultrasound in the evaluation and management of cerebral venous disease",
abstract = "Background: Intravascular ultrasound (IVUS) is an important diagnostic tool in many interventions, particularly coronary and carotid artery angioplasty and stenting. In contrast, its application in the management of diseases of the cerebral venous system remains an unexplored territory. We report three patients in whom IVUS was used during angiography for the evaluation of venous flow obstruction secondary to venous sinus thrombosis, venous sinus stenosis, and a transverse sinus mass lesion, respectively. In addition, we review current literature to summarize previous experience, focusing on the advantages and limitations of IVUS technology in interventional cardiology, carotid artery disease, and venous disease. Case Descriptions: In all three cases, IVUS was used without any complications and provided critical information that guided further management of these distinct diseases. IVUS helped diagnose the presence of intraluminal thrombus, severe stenosis, and a mass lesion in the transverse sinuses and also helped assess the response to angioplasty of the stenotic regions. Conclusions: IVUS is a promising tool that has potential to improve diagnostic accuracy and to guide the management of several diseases of the cerebral venous system. The cases we describe suggest that IVUS can be successfully used when performing endovascular interventions in patients with obstruction of venous outflow secondary to venous sinus stenosis, thrombosis, or mass lesions.",
keywords = "Cerebral venous stenosis, Cerebral venous thrombosis, Intravascular ultrasound imaging, Venous flow obstruction",
author = "Maxim Mokin and Peter Kan and Abla, {Adib A.} and Tareq Kass-Hout and Snyder, {Kenneth V.} and Levy, {Elad I.} and Siddiqui, {Adnan H.}",
note = "Funding Information: Conflict of interest statement: E. I. Levy receives research grant support (principal investigator: Stent-Assisted Recanalization in acute Ischemic Stroke, SARIS), other research support (devices), and honoraria from Boston Scientific* and research support from Codman & Shurtleff, Inc. and ev3/Covidien Vascular Therapies; has ownership interests in Intratech Medical Ltd. and Mynx/Access Closure; serves as a consultant on the board of Scientific Advisors to Codman & Shurtleff, Inc.; serves as a consultant per project and/or per hour for Codman & Shurtleff, Inc., ev3/Covidien Vascular Therapies, and TheraSyn Sensors, Inc.; and receives fees for carotid stent training from Abbott Vascular and ev3/Covidien Vascular Therapies. E. I. Levy receives no consulting salary arrangements. All consulting is per project and/or per hour. (*Boston Scientific{\textquoteright}s neurovascular business has been acquired by Stryker.). T. Kass-Hout has received grant support from Genentech . A. H. Siddiqui has received research grants from the National Institutes of Health (co-investigator: NINDS 1R01NS064592-01A1 , Hemodynamic induction of pathologic remodeling leading to intracranial aneurysms) and the University at Buffalo (Research Development Award); holds financial interests in Hotspur, Intratech Medical, StimSox, and Valor Medical; serves as a consultant to Codman & Shurtleff, Inc., Concentric Medical, ev3/Covidien Vascular Therapies, GuidePoint Global Consulting, and Penumbra; belongs to the speakers{\textquoteright} bureaus of Codman & Shurtleff, Inc. and Genentech; serves on an advisory board for Codman & Shurtleff; and has received honoraria from Abbott Vascular, American Association of Neurological Surgeons{\textquoteright} courses, an emergency medicine conference, Genentech, Neocure Group LLC, an Emergency Medicine Conference, Annual Peripheral Angioplasty and All That Jazz Course and from Abbott Vascular and Codman & Shurtleff, Inc. for training other neurointerventionists in carotid stenting and for training physicians in endovascular stenting for aneurysms. A. H. Siddiqui receives no consulting salary arrangements. All consulting is per project and/or per hour. K. V. Snyder serves as a consultant to, a member of the speakers{\textquoteright} bureau, and has received honoraria from Toshiba. He serves as a member of the speakers{\textquoteright} bureau for ev3 and The Stroke Group (consultants to the health care industry, Littleton CO) and has received honoraria from these entities. The remaining authors have no conflicts to report. The institutional review board at the University at Buffalo, State University of New York (Buffalo, New York, USA) approved this study (HSIRB Project #NEU3380811E), and a standard Health Insurance Portability and Accountability Act-compliant protocol was followed. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",
year = "2013",
month = nov,
doi = "10.1016/j.wneu.2012.04.004",
language = "English (US)",
volume = "80",
pages = "655.e7--655.e13",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
number = "5",
}